Northwood, OH – April 2016 – NAMSA, the world’s leading medical research organization, is pleased to announce the addition of Microbiological Compliance Laboratories (MCL) as NAMSA’s local agent in Costa Rica.
MCL is a microbiology and sterility assurance lab supporting US and European medical device and pharmaceutical manufacturers in the region. MCL provides local microbiology and endotoxin testing, monitoring of controlled environments and water systems, and sterilization validation support, as well as related consulting and training services.
“This strategic alliance will provide the medical device and pharmaceutical industries in Costa Rica access to services that were previously unavailable,” said, Jason Hoffbeck, President of MCL. “MCL’s local personnel and lab structures together with NAMSA’s global capabilities will provide the right technical expertise in sterilization, microbiology, and biocompatibility to help customers develop the best testing strategies for global regulatory requirements. We are excited for this opportunity to offer broader services in a more convenient and cost effective manner.”
“The alliance with MCL as a representing agent in Costa Rica demonstrates NAMSA’s commitment to global growth of service offerings and support for our clients around the world,” stated John Amat, NAMSA’s Chief Commercial Officer. “Their regional testing expertise provides our clients access to their knowledge and network, something that other CRO’s cannot.”
About Microbiological Compliance Laboratories
MCL ( http://www.mclmicro.com ) offers microbiology testing and consulting services to the medical device, pharmaceutical and life science sectors. Operating as an independently owned and Costa Rican based organization, active partners hold more than 55 years of microbiology experience working within the medical device industry. A small group of professional microbiologists who believe their experience and quality mindset can improve the quality of patient care through its customers and in a cost effective manner.
NAMSA (www.namsa.com) is a Medical Research Organization (MRO), accelerating medical device product development through integrated laboratory, clinical and consulting services. Driven by our regulatory expertise, NAMSA’s MRO® Approach plays an important role in translational research, applying a unique combination of disciplines—consulting, regulatory, preclinical, toxicology, microbiology, chemistry, clinical and quality—to move client’s products through the development process, and continue to provide support through commercialization to post-market requirements, anywhere in the world.
For further information about NAMSA or this news release, contact:
Chief Commercial Officer
6750 Wales Rd Northwood, OH 43619